findmyKOL

Risa Wolf, MD

Enriched profile

Associate Professor of Pediatrics, Director, Pediatric Diabetes Program · Johns Hopkins University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyPediatric EndocrinologyFocusDiabetes Management and Research+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2022–2025NIH funding2021–2026

Risa Wolf is Associate Professor of Pediatrics, Director, Pediatric Diabetes Program at Johns Hopkins University School of Medicine. OpenAlex indexes 159 publications with 2,295 citations (h-index 28); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 17 Oct 2026

Risa Wolf, M.D., is Associate Professor of Pediatrics, Director, Pediatric Diabetes Program at Johns Hopkins University School of Medicine. The public record shows 159 publications with 2,295 citations (h-index 28), centered on Diabetes Management and Research, Diabetes Management and Education, Diabetes and associated disorders. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 8 companies, 3 NIH-funded awards (2021–2026).

  • Most recent indexed publication: 2026 · Diabetes technology & therapeutics
  • Top research focus: Diabetes Management and Research
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 17 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 2 Diabetes4 trialsType 1 Diabetes4 trialsDiabetes Mellitus2 trialsHypoglycemia1 trialHyperglycemia1 trialCystic Fibrosis1 trialCysts1 trialMacular Degeneration (AMD)

Research focus

OpenAlex concept fingerprint
Diabetes Management and ResearchDiabetes Management and EducationDiabetes and associated disordersRetinal Imaging and AnalysisRetinal Diseases and Treatments

Drugs & molecules

across trials, industry payments and publications
Afrezzageneric · Insulin, regular, humanClinical trials—Industry payments5Publications—Tzieldgeneric · TeplizumabClinical trials—Industry payments4Publications—Baqsimigeneric · GlucagonClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
MannKind CorporationClinical trials—Industry payments5Johns Hopkins UniversityClinical trials4Industry payments—Abbott LaboratoriesClinical trials—Industry payments3Genzyme CorporationClinical trials—Industry payments3Insulet CorporationClinical trials—Industry payments2Beta Bionics, Inc.Clinical trials—Industry payments1Eli Lilly and CompanyClinical trials1Industry payments—Lilly USA, LLCClinical trials—Industry payments1Sanofi-Aventis U.S. LLCClinical trials—Industry payments1T1D Exchange, United StatesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
159publications

Distinct works indexed by OpenAlex, matched via ORCID; 40 in PubMed.

2,295citations

Total citations across indexed works.

28h-index

Hirsch index (OpenAlex). i10-index 49.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 17 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

All 6 trial records: search, sort and filter.Explore →

Industry payments

Updated 17 Oct 2026

8 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

All 11 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 17 Oct 2026

3 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

All 11 award records: search, sort and filter.Explore →

Congress activity

Updated 17 Oct 2026

26 congress contributions (2018–2025) across ADA per OpenAlex. The most recent:

All 26 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 17 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 40 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Obesity is associated with copper elevation in serum and tissues
    Article119 citations2019
    doi.org ↗
  2. 02
    Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial
    Article116 citations2024
    doi.org ↗
  3. 03
    Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
    Article109 citations2023
    doi.org ↗
  4. 04
    Foundational Considerations for Artificial Intelligence Using Ophthalmic Images
    Article96 citations2021
    doi.org ↗
  5. 05
    Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes
    Article87 citations2020
    doi.org ↗
All 159 cited works: search, sort and filter.Explore →

Network

Updated 17 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Roomasa Channa31Elizabeth A. Brown26Michael D. Abràmoff25Nestoras Nicolas Mathioudakis22Laura M. Prichett17T. Y. Alvin Liu16Guang William Wong14Dhruva Patel13Harold P. Lehmann13Aniket R Sidhaye13Sheela Natesh Magge12Bernard Pan11Neha Parimi11MEREDITH R. THIVIERGE10Maureen Seel9Tyger Lin9ELIZABETH A. BROWN9Jessica M. Valenzuela9Osagie A. Ebekozien9AMY SANGHAVI SHAH8MARY PAT GALLAGHER8Kimberley Eden Steele8Michelle Anne Van Name8William V. Tamborlane7Sarah Kanbour7CHRYSTAL G. THOMAS7Samuel M. Vanderhoek7Brynn E. Marks7Robin L. Gal7GEORGEANNA JONES KLINGENSMITH7Nicole A. Rioles7Ashley Hall Shoemaker6Mohammed S. Abusamaan6Lindsey C. Beaulieu6Peiyao Cheng6Michael Schweitzer6Margaret J. West6Abha Choudhary5Bliss Magella5Meg C N Snyder5

Online presence

Updated 17 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/risa-wolf-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    clinicalconnection.hopkinsmedicine.org/participant/risa-wolf-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clinicalconnection.hopkinsmedicine.org ↗
  • Other

    events.diabetes.org/speakers/148/view

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →events.diabetes.org ↗
  • Other

    pure.johnshopkins.edu/en/persons/risa-wolf

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pure.johnshopkins.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 17 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Board of Directors

    Breakthrough T1D Mid-Atlantic Chapter

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →breakthrought1d.org ↗
  • Member

    American Diabetes Association Eye Health Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
  • Co-chair

    Hopkins Business of Health Initiative Workgroup on AI and Healthcare

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
  • Founder and Medical Director

    Camp Charm City diabetes camp

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.